Abstract
During development a large number of molecules are rejected as drug candidates due to unfavorable ADMET (absorption, distribution, metabolism, excretion and toxicity). In Silico ADMET predictions early in development may shorten drug discovery timelines. QSAR modeling of relationships between molecular descriptors (MDs) and activity profiles is a well known approach for predicting ADMET properties. Inhibitors of thermolysin and other thermolysin like zinc-metalloproteases are promising as therapeutic compounds. In the present paper ADMET parameters of 25 thermolysin inhibitors were predicted using QSAR models derived from multiple linear regressions (MLR) analysis and artificial neural network using the web-based tool PreADME version 1.0 (http://preadmet.bmdrc.org/preadmet/index.php). The QSAR models indicated that best correlation was obtained between polar surface area (PSA) and the MDs. PSA is important for bioavailability of the compound. The model had a regression coefficient (R2) of 0.915 (p < 0.001).
Keywords: Thermolysin inhibitor, ADMET prediction, Molecular descriptor, Artificial neural network, Mutagenicity, Carcinogenicity
Letters in Drug Design & Discovery
Title: Multivariate Linear Regression Models Based on ADME Descriptors and Predictions of ADMET Profile for Structurally Diverse Thermolysin Inhibitors
Volume: 6 Issue: 6
Author(s): Mahmud Tareq Hassan Khan and Ingebrigt Sylte
Affiliation:
Keywords: Thermolysin inhibitor, ADMET prediction, Molecular descriptor, Artificial neural network, Mutagenicity, Carcinogenicity
Abstract: During development a large number of molecules are rejected as drug candidates due to unfavorable ADMET (absorption, distribution, metabolism, excretion and toxicity). In Silico ADMET predictions early in development may shorten drug discovery timelines. QSAR modeling of relationships between molecular descriptors (MDs) and activity profiles is a well known approach for predicting ADMET properties. Inhibitors of thermolysin and other thermolysin like zinc-metalloproteases are promising as therapeutic compounds. In the present paper ADMET parameters of 25 thermolysin inhibitors were predicted using QSAR models derived from multiple linear regressions (MLR) analysis and artificial neural network using the web-based tool PreADME version 1.0 (http://preadmet.bmdrc.org/preadmet/index.php). The QSAR models indicated that best correlation was obtained between polar surface area (PSA) and the MDs. PSA is important for bioavailability of the compound. The model had a regression coefficient (R2) of 0.915 (p < 0.001).
Export Options
About this article
Cite this article as:
Khan Tareq Hassan Mahmud and Sylte Ingebrigt, Multivariate Linear Regression Models Based on ADME Descriptors and Predictions of ADMET Profile for Structurally Diverse Thermolysin Inhibitors, Letters in Drug Design & Discovery 2009; 6 (6) . https://dx.doi.org/10.2174/157018009789057607
DOI https://dx.doi.org/10.2174/157018009789057607 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant Effect of Mangiferin and its Potential to be a Cancer Chemoprevention Agent
Letters in Drug Design & Discovery Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Nanoparticle-based Drug Delivery Systems for Solid Brain Tumors
Current Nanoscience Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Neurosarcoidosis
Current Neuropharmacology Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension
Current Pharmaceutical Design Similar Mechanisms Regulated by γ-Secretase are Involved in Both Directions of the Bi-Directional Notch-Delta Signaling Pathway as well as Play a Potential Role in Signaling Events Involving Type 1 Transmembrane Proteins
Current Stem Cell Research & Therapy Anthrax Fusion Protein Therapy of Cancer
Current Protein & Peptide Science Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric Cancer
Current Cancer Drug Targets Aging and DNA Methylation
Current Chemical Biology Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Current Pharmaceutical Biotechnology Notch Signaling in Leukemias and Lymphomas
Current Molecular Medicine Potential Health Benefits of Berries
Current Nutrition & Food Science Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Reviews on Recent Clinical Trials Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
Current Drug Targets Looking Beyond Inhibition of VEGF/mTOR: Emerging Targets for Renal Cell Carcinoma Drug Development
Current Clinical Pharmacology Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry